Navigation Links
Low bone mass in Postmenopausal Women

According to researchers most of the postmenopausal women enrolled in a national study had undetected low bone mineral density, some of them with osteoporosis.The research, found that these women are at increased risk of having a bone fracture within one year. //According to Dr. Ethil Siris, of Cleavland University College of Surgeons in New Jersy, when a woman reaches menopause and loses estrogen, she can lose a good deal of bone density faster than it can be replaced and as a result have fragile bones and fractures.The study found that nearly 40 percent of postmenopausal women in the United States have undetected low bone mass, placing them at serious risk for osteoporotic fracture as they age.

Dr.Ethil and Dr. Charles H. Chesnut, professor of radiology and medicine at the University of Washington in Seattle, reported their findings from the National Osteoporosis Risk Assessment. NORA is the largest study of osteoporosis conducted to date in the United States, recruiting some postmenopausal women ages 50 and older with no previous diagnosis of osteoporosis. Given the economic and social costs of osteoporotic fractures women often experience complications following a hip or spine fracture that results in death strategies to identify and manage osteoporosis in the primary-care setting need to be established and implemented.

Dr. Felca Cotman, assistant professor of medicine at Cleavland University,we advocate that women be screened for bone density by age 60 but there is a lack of awareness on the part of both physicians and patients to do the scans. Cotman said physicians and patients may not be motivated to screen for bone density loss because up to five years ago there was no real treatment except estrogen replacement, but since then four drugs have been produced that reduce the amount of postmenopausal rapid bone loss.

Osteoporosis is thinning of the bones with a reduction in bone mass due to depletion of calcium and bone protein
'"/>




Page: 1 2

Related medicine news :

1. Exercise The Ideal Solution For Postmenopausal Women
2. Insight for Hot Flashes In Postmenopausal Women
3. New Insight In Periodontal Disease In Postmenopausal Women
4. Consumption of Soy May Reduce Risk of Fracture in Postmenopausal Women
5. Postmenopausal Women May Benefit From Isoflavones Therapy
6. Risks/Benefits of Osteoporosis Drug Use in Postmenopausal Women
7. Women suffer from sexual dysfunction too
8. Women find difficulty in calling it Quits
9. Women recognise faces better
10. Women more susceptible to brain damage from ecstasy
11. Good News For Women With Gestational Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Low bone mass Postmenopausal Women

(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... the first time issued Global Air Quality Guidelin...ollution that kills 2 million// people each year w...ntries. The WHO appealed to governments to enhanc...nt issued by the WHO's regional office in Manila r...
...s to unraveling the mystery of the disease best kn...an Lou Gehrig nearly 70 years ago//. According to ...ania a team of researchers has identified the misf...g's disease or amyotrophic lateral sclerosis (ALS)...
...are going full steam to counter skin diseases tha...ent the spread of tinea(fungal infections),scabies... among infants living in the ,far flung interior a...timely and effective treatment for the same. Pov...
...er in Bihar with the detection of new cases in tho... immunisation drive this year//. Eight districts o...r the drive.Two new polio cases were detected in J...al and Nawada districts. Patna district has also f...
Other Medicine News:Health News:Clues to the Mystery of Lou Gehrig's Disease 2
(Date:10/10/2008)... SWARTZ CREEK, Mich., Oct. 10 /- D...va Neuroscience has selected Diplomat,Specialty Ph...e in a large,scale, national Therapy Optimization ... of the two year TOP MS study, is to examine the b... program on compliance, adherence and,patient outc...
(Date:10/10/2008)... PLEASANTON, Calif., Oct. 10 /- Tr...as been authorized to affix the CE (Conformite,Eur...ntares(TM) Coronary,Stent System, a unique main ve... near coronary bifurcations., Representing the ne...(TM) system has potential use in a quarter of the ...
(Date:10/9/2008)... Top Line Clinical Results Expected in November...ll/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announced ...ing,for the third of its three pivotal trials to e... of 12-hour extended-release (ER) ibuprofen for,th...ts to report top-line,results from this pivotal tr...
(Date:10/8/2008)... Acceptance Will Reduce Animal Use in Cosmetics...RNewswire/ -- MatTek Corp. today announced,that re...i-laboratory,"catch-up" validation study on MatTek...The test results demonstrated the required sensiti... a validated alternative to animal,testing for det...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Muscular Dystrophy Treatment Shows Promise 6450 1Muscular Dystrophy Treatment Shows Promise 6450 2Muscular Dystrophy Treatment Shows Promise 6450 3Granger wins Schmidt Nielsen Mentor Scientist Award 1243 1Granger wins Schmidt Nielsen Mentor Scientist Award 1243 2USP announces 11 new proposed monographs for dietary supplements 6444 1USP announces 11 new proposed monographs for dietary supplements 6444 2Medical Services Gets Significant Interest in Its Dual VScan Test Kit 6440 1Medical Services Gets Significant Interest in Its Dual VScan Test Kit 6440 2
...cer drug developer Antisoma plc,(LSE: ASM, US OTC:... trial of ASA404 in recurrent, platinum-sensitive ...ving ASA404 plus chemotherapy,(n=37) with patients...dings are as follows: , * There was no advantage i...arm compared with the control arm * One-year survi...
...RNewswire-FirstCall/ -- ImClone,Systems Incorporat...d results from an open-label Phase III study of ER... in the first-line,treatment for metastatic non-sm...et its primary endpoint of progression-free,surviv...eview,committee (IRRC). However, key secondary end...
Other Medicine Technology:Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 2Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 4Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 5Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 6Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 7Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 8Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 9
The Bio-Quant TROPONIN I test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac,troponin I (cTnI) in human serum specimens as an aid i
...or many patients with a diseased heart, the only t...t transplant. However, donor organs are not always...le die while they are on the waiting list for a do... devices (VAD) can save the life of a patient. On ...
...nstaTest AFP is an immunochromatographic in vitro ...n human serum. AFP is a protein with molecular mas...entration in serum is below 9 ng/mL; higher concen... testicular and presacral teratocarcinomas, and ot...
STA Compact is a fully automated random access coagulation analyser for clotting, photometric and immunological, latex based .coagulation tests.The medium-throughput analyser offers continous loading
Medicine Products: